Worldia(SH:688028)2022-04-19 16:00Financial Performance - The company's operating revenue for 2021 was CNY 325,809,094.85, representing a 34.73% increase compared to CNY 241,831,705.19 in 2020[22]. - The net profit attributable to shareholders for 2021 was CNY 54,449,991.68, a 10.02% increase from CNY 49,490,793.88 in 2020[22]. - The net profit after deducting non-recurring gains and losses was CNY 47,366,168.66, up 3.98% from CNY 45,552,729.82 in 2020[22]. - The net cash flow from operating activities was CNY 70,734,829.13, a decrease of 5.06% compared to CNY 74,506,478.78 in 2020[22]. - The company's total assets at the end of 2021 were CNY 931,417,579.94, reflecting a 3.71% increase from CNY 898,118,779.03 at the end of 2020[22]. - The basic earnings per share for 2021 were CNY 0.68, a 9.68% increase from CNY 0.62 in 2020[23]. - The company's net profit attributable to shareholders increased by 10.02% year-on-year, while the net profit excluding non-recurring gains and losses grew by 3.98%[24]. - Operating cash flow decreased by 5.06% compared to the previous year, primarily due to increased cash payments for goods and services as well as higher employee compensation[24]. - The gross profit margin was 49.22%, an increase of 2.25 percentage points compared to the same period last year; net profit attributable to shareholders was 54.45 million yuan, up 10.02%[34]. Dividend Policy - The company plans to distribute a cash dividend of 1.9 CNY per 10 shares, totaling approximately 15.2 million CNY, which represents 69.05% of the net profit attributable to shareholders for the year 2021[6]. - The cash dividend amount is based on an estimated total share capital of 80 million shares, subject to adjustment based on the actual share capital on the dividend record date[6]. - The company does not plan to increase capital reserves or issue bonus shares, with remaining undistributed profits carried forward to the next year[6]. - The company plans to distribute a cash dividend of 2.5 yuan per 10 shares (including tax), totaling 20 million yuan, which accounts for 85.67% of the net profit attributable to shareholders for the year 2020[156]. - The company plans to distribute a cash dividend of 2.8 RMB per 10 shares (including tax) for the first half of 2021, totaling 22.4 million RMB, which accounts for 72.99% of the net profit attributable to shareholders for the same period[157]. Research and Development - Research and development expenses accounted for 8.66% of operating revenue, an increase of 1.29 percentage points from 7.37% in 2020[23]. - The total R&D investment increased by 58.22% year-on-year, amounting to approximately ¥28.21 million, representing 8.66% of total revenue[65]. - The company is focusing on expanding its R&D efforts and enhancing its product offerings to drive future growth[25]. - The company has over 15 years of research and development in CVD diamond preparation and application, mastering three major CVD diamond growth technologies[52]. - The company has launched PCD micro-drills with diameters below 2mm, showing superior performance in terms of lifespan and processing stability compared to traditional carbide micro-drills[57]. - The company has developed advanced core technologies, including laser micro-nano precision processing and CVD diamond growth technology, with production precision reaching micron and sub-micron levels[56]. Market Expansion and Strategy - The company achieved significant market breakthroughs in the wind power sector and strengthened its position in the domestic market while expanding overseas operations[22]. - The company plans to enhance its international market presence through its German subsidiary and aims for global supply capabilities[116]. - The company is focusing on developing cultivated diamonds and diamond functional materials, with a full industry chain layout including CVD diamond growth and processing[117]. - The company is actively pursuing innovative cutting tools to address challenges in machining hardened steel, thereby enhancing operational efficiency[72]. - The company plans to enhance its market expansion efforts and aims to build its products into internationally competitive brands[77]. Corporate Governance - The company has not disclosed any special arrangements for corporate governance[9]. - The company emphasizes the importance of understanding the difference between plans, forecasts, and commitments in its forward-looking statements[8]. - The company strictly adhered to insider information management regulations, ensuring no insider trading incidents occurred during the reporting period[126]. - The company held three shareholder meetings during the reporting period, all resolutions were passed legally and effectively[127]. - The company has established a governance structure involving the shareholders' meeting, board of directors, supervisory board, and management, ensuring clear responsibilities and effective operations[174]. Compliance and Risk Management - The company has established a risk management and compliance system, integrating internal control measures to prevent operational risks in subsidiaries[171]. - The company has not faced any penalties from securities regulatory authorities in the past three years[144]. - The company has not been identified as a key greenhouse gas emitter and has implemented measures to reduce emissions through process optimization and equipment upgrades[178][184]. - The company has established a comprehensive investor rights protection system, ensuring accurate and timely information disclosure to safeguard shareholder interests[189]. Employee and Social Responsibility - The total number of employees in the parent company and major subsidiaries is 730, with 408 in production, 62 in sales, 111 in technical roles, 12 in finance, and 137 in administration[153]. - The company has implemented a salary optimization strategy to enhance employee compensation, particularly for technical research and development positions, linking salaries to overall company performance[154]. - The company provided free masks and disinfectants to employees during the COVID-19 pandemic and organized multiple rounds of nucleic acid testing and vaccination[197]. - The company donated 100,000 yuan to charity during the reporting period, reflecting its commitment to social responsibility[188].